Related Experiment Videos
Length of antibiotic therapy in in-patients with primary pneumonias
Abstract:
Seventy-three subjects with primary pneumonia in a hospital in Northern Nigeria were given antibiotics until they had been afebrile for 24 hours. The average duration of therapy was 2.54 days (about 60 hours), which is considerably shorter than the current recommended practice. Subjects with hepatosplenomegalic schistosomiasis and tropical splenomegaly syndrome required antibiotics for a significantly longer period (3.75 days) than those without either of these conditions. Those with an antigenaemia did not require antibiotics for a significantly longer period than those without an antigenaemia. There were no deaths, no increase in morbidity and in virtually all cases complete resolution of the lung lesion occurred within the expected time. It is suggested that in primary pneumonia it is more rational to stop antibiotics after the patient has been afebrile for 24 hours. This leads to a shorter stay in hospital and to the use of less antibiotic.
Insights
Stopping antibiotic treatment for primary pneumonia after 24 hours of being afebrile is effective. This shorter antibiotic duration reduces hospital stays and medication use in Nigerian patients.
Area of Science:
- Infectious Diseases
- Clinical Medicine
- Pharmacology
Background:
- Primary pneumonia is a common respiratory infection.
- Current antibiotic guidelines often recommend longer treatment durations.
- Factors like co-infections can influence treatment length.
Purpose of the Study:
- To evaluate a shorter antibiotic regimen for primary pneumonia.
- To determine if stopping antibiotics after 24 hours of being afebrile is effective.
- To compare treatment duration in patients with and without specific co-existing conditions.
Main Methods:
- A study involving 73 subjects with primary pneumonia in Northern Nigeria.
- Antibiotic therapy was administered until patients were afebrile for 24 hours.
- Treatment duration was compared between subjects with and without hepatosplenomegalic schistosomiasis, tropical splenomegaly syndrome, and antigenaemia.
Main Results:
- Average antibiotic therapy duration was 2.54 days, significantly shorter than standard practice.
- Subjects with hepatosplenomegalic schistosomiasis or tropical splenomegaly syndrome required longer treatment (3.75 days).
- No deaths or increased morbidity were observed; complete lung lesion resolution occurred as expected.
Conclusions:
- A 24-hour afebrile period is a rational endpoint for primary pneumonia antibiotic therapy.
- Shorter antibiotic courses lead to reduced hospital stays and less medication use.
- This approach is safe and effective, even with certain co-existing tropical conditions.